Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
39
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dugan Margaret | Director | 9 | $0 | $0 | 2025-05-21 |
| Riva Alessandro | Director | 9 | $0 | $0 | 2025-05-21 |
| Sanders Corazon (Corsee) D. | Director | 13 | $0 | $105.4K | 2025-05-21 |
| Yi Qingqing | Director | 17 | $0 | $0 | 2025-05-21 |
| BRANDICOURT OLIVIER | Director | 5 | $0 | $0 | 2025-05-21 |
| Sharp Shalini | Director | 4 | $0 | $0 | 2025-05-21 |
| HOOPER ANTHONY C | Director | 12 | $0 | $0 | 2025-05-21 |
| Wang Xiaodong | Director | 308 | $0 | $128.82M | 2025-05-13 |
| OYLER JOHN | Chief Executive Officer | 679 | $0 | $466.67M | 2025-05-09 |
| Wu Xiaobin | President, COO & GM China | 134 | $0 | $67.28M | 2025-04-01 |
| Rosenberg Aaron | Chief Financial Officer | 3 | $0 | $0 | 2025-03-05 |
| Lee Chan Henry | SVP, General Counsel | 15 | $0 | $1.30M | 2025-03-05 |
| Wang Lai | Global Head of R&D | 45 | $0 | $4.49M | 2025-03-05 |
| Baker Brothers Life Sciences LP | Director, 10% Owner | 10 | $256.34M | $392.75M | 2024-12-09 |
| Hillhouse Capital Management, Ltd. | 10% Owner | 10 | $0 | $4.17B | 2024-12-02 |
| Ball Titus B. | Principal Accounting Officer | 3 | $0 | $26.0K | 2024-09-03 |
| Wang Julia Aijun | Chief Financial Officer | 22 | $0 | $1.00M | 2024-07-01 |
| Glazer Donald W. | Director | 48 | $0 | $12.66M | 2024-06-05 |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | 15 | $640.42M | $0 | 2024-06-05 |
| 667, L.P. | Director, 10% Owner | 7 | $0 | $0 | 2023-06-15 |
| Malley Thomas | Director | 12 | $960.0K | $0 | 2023-06-15 |
| HHLR ADVISORS, LTD. | 10% Owner | 4 | $0 | $226.30M | 2023-06-14 |
| Huang Jane | CMO, Hematology | 300 | $0 | $39.74M | 2021-12-14 |
| AMGEN INC | 10% Owner | 12 | $50.00M | $0 | 2021-09-10 |
| Liang Howard | CFO & Chief Strategy Officer | 89 | $120.3K | $48.84M | 2021-06-28 |
| Chen Timothy Yung-Cheng | Director | 54 | $0 | $6.37M | 2021-06-16 |
| su Jingshyh S | Director | 5 | $0 | $0 | 2021-06-16 |
| BAKER JULIAN | Director, 10% Owner | 5 | $0 | $0 | 2021-06-16 |
| BAKER FELIX | Director, 10% Owner | 6 | $0 | $360.01M | 2021-01-04 |
| Baker Bros. Advisors (GP) LLC | Director, 10% Owner | 7 | $0 | $0 | 2020-06-17 |
| Peterson Amy C. | CMO, Immuno-oncology | 54 | $0 | $8.76M | 2018-12-18 |
| Li Ji | EVP and Gl. Head of Bus. Dev. | 12 | $0 | $1.47M | 2018-02-28 |
| Tang Ke | Director | 1 | $0 | $0 | 2017-04-19 |
| 14159, L.P. | Director, 10% Owner | 19 | $45.90M | $0 | 2017-04-19 |
| Yan Wendy Xiaojun | Sr. VP, Head of Reg. Affairs | 1 | $0 | $0 | 2016-07-13 |
| Yang Jianxin | Sr. VP, Head of Clinical Dev. | 1 | $0 | $0 | 2016-07-13 |
| Merck Sharp & Dohme Corp. | 10% Owner | 5 | $0 | $0 | 2016-02-08 |
| CITIC PE Associates, L.P. | 10% Owner | 3 | $0 | $0 | 2016-02-08 |
| Yuan RuiRong | Chief Medical Officer | 1 | $240.5K | $0 | 2016-02-08 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| HOOPER ANTHONY C | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 22,750 | — | $0 | 22,750 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 22,750 | — | $0 | 22,750 | SEC↗ |
| Dugan Margaret | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 22,750 | — | $0 | 22,750 | SEC↗ |
| Riva Alessandro | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 22,750 | — | $0 | 22,750 | SEC↗ |
| BRANDICOURT OLIVIER | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 22,750 | — | $0 | 22,750 | SEC↗ |
| Sharp Shalini | Director | A Award deriv | 2025-05-21 | 2025-05-22 | 22,750 | — | $0 | 22,750 | SEC↗ |
| Yi Qingqing | Director | A Award deriv | 2025-05-21 | 2025-05-23 | 22,750 | — | $0 | 22,750 | SEC↗ |
| HOOPER ANTHONY C | Director | A Award | 2025-05-21 | 2025-05-22 | 10,985 | — | $0 | 64,740 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award | 2025-05-21 | 2025-05-22 | 10,985 | — | $0 | 57,226 | SEC↗ |
| Dugan Margaret | Director | A Award | 2025-05-21 | 2025-05-22 | 10,985 | — | $0 | 56,940 | SEC↗ |
| Riva Alessandro | Director | A Award | 2025-05-21 | 2025-05-22 | 10,985 | — | $0 | 56,940 | SEC↗ |
| BRANDICOURT OLIVIER | Director | A Award | 2025-05-21 | 2025-05-22 | 10,985 | — | $0 | 27,326 | SEC↗ |
| Sharp Shalini | Director | A Award | 2025-05-21 | 2025-05-22 | 10,985 | — | $0 | 19,136 | SEC↗ |
| Yi Qingqing | Director | A Award | 2025-05-21 | 2025-05-23 | 10,985 | — | $0 | 56,940 | SEC↗ |
| Wang Xiaodong | Director | M Exercise deriv | 2025-05-13 | 2025-05-15 | 542,880 | — | $0 | 542,887 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-05-13 | 2025-05-15 | 21,235 | $223.41 | $4.74M | 10,304 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-05-13 | 2025-05-15 | 200 | $225.68 | $45.1K | 0 | SEC↗ |
| Wang Xiaodong | Director | M Exercise | 2025-05-13 | 2025-05-15 | 41,760 | $6.50 | $271.4K | 41,760 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-05-13 | 2025-05-15 | 10,104 | $224.32 | $2.27M | 200 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-05-13 | 2025-05-15 | 10,221 | $222.83 | $2.28M | 31,539 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise deriv | 2025-05-09 | 2025-05-13 | 4,055,415 | — | $0 | 7 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-05-09 | 2025-05-13 | 4,055,415 | $0.50 | $2.03M | 10,154,040 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | F Tax w/h | 2025-05-09 | 2025-05-13 | 1,990,603 | $17.85 | $35.53M | 8,163,437 | SEC↗ |
| Wang Xiaodong | Director | M Exercise deriv | 2025-04-14 | 2025-04-16 | 542,880 | — | $0 | 1,085,767 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 6,398 | $243.41 | $1.56M | 7,892 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 15,041 | $242.59 | $3.65M | 14,290 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 2,229 | $241.51 | $538.3K | 29,331 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 5,516 | $240.41 | $1.33M | 31,560 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 2,884 | $239.51 | $690.7K | 37,076 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 805 | $238.48 | $192.0K | 39,960 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 995 | $237.56 | $236.4K | 40,765 | SEC↗ |
| Wang Xiaodong | Director | M Exercise | 2025-04-14 | 2025-04-16 | 41,760 | $6.50 | $271.4K | 41,760 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 365 | $249.45 | $91.0K | 0 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 535 | $248.90 | $133.2K | 365 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 1,475 | $247.46 | $365.0K | 900 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 1,869 | $246.40 | $460.5K | 2,375 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 2,056 | $245.56 | $504.9K | 4,244 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-04-14 | 2025-04-16 | 1,592 | $244.56 | $389.3K | 6,300 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise deriv | 2025-04-01 | 2025-04-03 | 460,772 | — | $0 | 296,049 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise deriv | 2025-04-01 | 2025-04-03 | 214,201 | — | $0 | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-04-01 | 2025-04-03 | 12,221 | $282.76 | $3.46M | 5,083 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-04-01 | 2025-04-03 | 6,364 | $281.67 | $1.79M | 17,304 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-04-01 | 2025-04-03 | 5,083 | $283.79 | $1.44M | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise | 2025-04-01 | 2025-04-03 | 16,477 | $119.96 | $1.98M | 16,477 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise | 2025-04-01 | 2025-04-03 | 35,444 | $174.43 | $6.18M | 51,921 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-04-01 | 2025-04-03 | 28,253 | $280.31 | $7.92M | 23,668 | SEC↗ |
| Wang Xiaodong | Director | M Exercise deriv | 2025-03-18 | 2025-03-20 | 542,880 | — | $0 | 1,628,647 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-18 | 2025-03-20 | 2,694 | $259.86 | $700.1K | 29,723 | SEC↗ |
| Wang Xiaodong | Director | M Exercise | 2025-03-18 | 2025-03-20 | 41,760 | $6.50 | $271.4K | 41,760 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-18 | 2025-03-20 | 2,417 | $258.25 | $624.2K | 39,343 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-18 | 2025-03-20 | 6,926 | $259.08 | $1.79M | 32,417 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-18 | 2025-03-20 | 10,448 | $261.44 | $2.73M | 19,275 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-18 | 2025-03-20 | 11,245 | $262.12 | $2.95M | 8,030 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-18 | 2025-03-20 | 6,923 | $263.08 | $1.82M | 1,107 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-18 | 2025-03-20 | 1,107 | $264.01 | $292.3K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-03-14 | 2025-03-18 | 0 | — | $0 | 0 | SEC↗ |
| Wang Xiaodong | Director | G Gift | 2025-03-11 | 2025-03-13 | 158,717 | — | $0 | 5,082,165 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise deriv | 2025-03-10 | 2025-03-12 | 1,033,552 | — | $0 | 4,055,422 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 1,900 | $238.74 | $453.6K | 39,310 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 9,309 | $243.04 | $2.26M | 13,932 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 7,069 | $241.92 | $1.71M | 23,241 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 2,200 | $240.70 | $529.5K | 30,310 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 6,800 | $239.59 | $1.63M | 32,510 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 5,313 | $244.04 | $1.30M | 8,619 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-03-10 | 2025-03-12 | 41,210 | $6.50 | $267.9K | 41,210 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-03-10 | 2025-03-12 | 497,822 | $0.50 | $248.9K | 6,098,625 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 700 | $246.85 | $172.8K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 4,913 | $246.11 | $1.21M | 700 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-10 | 2025-03-12 | 3,006 | $245.19 | $737.0K | 5,613 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise deriv | 2025-03-07 | 2025-03-07 | 1,470,417 | — | $0 | 5,088,974 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-03-07 | 2025-03-07 | 58,590 | $6.50 | $380.8K | 58,590 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-03-07 | 2025-03-07 | 708,747 | $0.50 | $354.4K | 5,600,803 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 500 | $256.10 | $128.1K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 2,400 | $255.02 | $612.0K | 500 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 1,300 | $254.10 | $330.3K | 2,900 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 1,100 | $253.21 | $278.5K | 4,200 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 3,299 | $252.24 | $832.1K | 5,300 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 2,300 | $251.00 | $577.3K | 8,599 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 12,578 | $249.97 | $3.14M | 10,899 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 8,905 | $249.04 | $2.22M | 23,477 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 7,600 | $247.99 | $1.88M | 32,382 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 13,918 | $246.91 | $3.44M | 39,982 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 1,190 | $246.69 | $293.6K | 53,900 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 2,100 | $246.10 | $516.8K | 55,090 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-07 | 2025-03-07 | 1,400 | $246.03 | $344.4K | 57,190 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise deriv | 2025-03-06 | 2025-03-07 | 1,007,578 | — | $0 | 6,559,391 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-06 | 2025-03-07 | 8,200 | $258.91 | $2.12M | 14,811 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-06 | 2025-03-07 | 1,700 | $262.97 | $447.0K | 100 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-06 | 2025-03-07 | 3,400 | $262.03 | $890.9K | 1,800 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-06 | 2025-03-07 | 2,906 | $261.08 | $758.7K | 5,200 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-06 | 2025-03-07 | 6,705 | $259.77 | $1.74M | 8,106 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-06 | 2025-03-07 | 100 | $264.27 | $26.4K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-06 | 2025-03-07 | 13,598 | $257.92 | $3.51M | 23,011 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-06 | 2025-03-07 | 3,500 | $256.91 | $899.2K | 36,609 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-03-06 | 2025-03-07 | 40,109 | $6.50 | $260.7K | 40,109 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-03-06 | 2025-03-07 | 486,161 | $0.50 | $243.1K | 4,892,056 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise deriv | 2025-03-05 | 2025-03-07 | 583,349 | — | $0 | 214,201 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise deriv | 2025-03-05 | 2025-03-07 | 91,624 | — | $0 | 2 | SEC↗ |
| Rosenberg Aaron | Chief Financial Officer | A Award | 2025-03-05 | 2025-03-07 | 48,581 | — | $0 | 167,128 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | A Award | 2025-03-05 | 2025-03-07 | 40,209 | — | $0 | 246,142 | SEC↗ |
| Wang Lai | Global Head of R&D | A Award | 2025-03-05 | 2025-03-07 | 69,251 | — | $0 | 990,171 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-03-05 | 2025-03-07 | 200 | $263.00 | $52.6K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-03-05 | 2025-03-07 | 22,537 | $262.51 | $5.92M | 200 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-03-05 | 2025-03-07 | 11,360 | $261.61 | $2.97M | 22,737 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-03-05 | 2025-03-07 | 17,824 | $260.39 | $4.64M | 34,097 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise | 2025-03-05 | 2025-03-07 | 44,873 | $119.96 | $5.38M | 51,921 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise | 2025-03-05 | 2025-03-07 | 7,048 | $169.65 | $1.20M | 7,048 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | A Award | 2025-03-05 | 2025-03-07 | 103,883 | — | $0 | 1,175,210 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | A Award | 2025-03-05 | 2025-03-07 | 201,084 | — | $0 | 4,405,895 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-04 | 2025-03-06 | 2,000 | $252.72 | $505.4K | 5,446 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-04 | 2025-03-06 | 700 | $251.70 | $176.2K | 7,446 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-04 | 2025-03-06 | 825 | $253.55 | $209.2K | 4,621 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-04 | 2025-03-06 | 1,275 | $254.77 | $324.8K | 3,346 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-04 | 2025-03-06 | 1,214 | $255.71 | $310.4K | 2,132 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-04 | 2025-03-06 | 1,809 | $256.83 | $464.6K | 323 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-03-04 | 2025-03-06 | 323 | $257.41 | $83.1K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise deriv | 2025-03-03 | 2025-03-05 | 2,533,531 | — | $0 | 7,566,969 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-03-03 | 2025-03-05 | 1,220,531 | $0.50 | $610.3K | 4,199,364 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2025-03-03 | 2025-03-05 | 101,000 | $6.50 | $656.5K | 101,000 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 5,956 | $240.53 | $1.43M | 95,044 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 13,816 | $241.38 | $3.33M | 81,228 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 8,192 | $242.46 | $1.99M | 73,036 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 11,195 | $243.44 | $2.73M | 61,841 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 600 | $249.25 | $149.6K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 3,900 | $248.63 | $969.7K | 600 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 6,480 | $247.63 | $1.60M | 4,500 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 7,243 | $246.57 | $1.79M | 10,980 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 19,232 | $245.51 | $4.72M | 18,223 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 1,090 | $245.36 | $267.4K | 37,455 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 18,386 | $244.56 | $4.50M | 38,545 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2025-03-03 | 2025-03-05 | 4,910 | $244.45 | $1.20M | 56,931 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-02-28 | 2025-03-04 | 0 | — | $0 | 0 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2025-02-27 | 2025-03-03 | 1,205 | $275.00 | $331.4K | 0 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2025-02-21 | 2025-02-25 | 100 | $260.22 | $26.0K | 0 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2025-02-21 | 2025-02-25 | 598 | $258.69 | $154.7K | 100 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2025-02-21 | 2025-02-25 | 504 | $256.84 | $129.4K | 698 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2025-02-21 | 2025-02-25 | 479 | $256.70 | $123.0K | 2,619 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2025-02-21 | 2025-02-25 | 1,327 | $254.82 | $338.1K | 3,673 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2025-02-21 | 2025-02-25 | 575 | $255.86 | $147.1K | 3,098 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2025-02-21 | 2025-02-25 | 437 | $258.18 | $112.8K | 2,182 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2025-02-21 | 2025-02-25 | 1,782 | $258.73 | $461.1K | 400 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2025-02-21 | 2025-02-25 | 400 | $260.17 | $104.1K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise deriv | 2025-02-20 | 2025-02-20 | 276,471 | — | $0 | 91,626 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise | 2025-02-20 | 2025-02-20 | 21,267 | $169.65 | $3.61M | 21,267 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-02-20 | 2025-02-20 | 21,267 | $240.07 | $5.11M | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise deriv | 2025-02-18 | 2025-02-20 | 398,502 | — | $0 | 368,097 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | M Exercise | 2025-02-18 | 2025-02-20 | 30,654 | $169.65 | $5.20M | 30,654 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-02-18 | 2025-02-20 | 19,576 | $240.31 | $4.70M | 11,078 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-02-18 | 2025-02-20 | 3,159 | $242.08 | $764.7K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2025-02-18 | 2025-02-20 | 7,919 | $241.26 | $1.91M | 3,159 | SEC↗ |
| Wang Xiaodong | Director | M Exercise deriv | 2025-02-04 | 2025-02-06 | 542,880 | — | $0 | 2,171,527 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-02-04 | 2025-02-06 | 9,776 | $227.00 | $2.22M | 1,400 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-02-04 | 2025-02-06 | 17,805 | $226.35 | $4.03M | 11,176 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-02-04 | 2025-02-06 | 2,161 | $225.27 | $486.8K | 28,981 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-02-04 | 2025-02-06 | 1,400 | $228.04 | $319.3K | 0 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-02-04 | 2025-02-06 | 9,099 | $223.00 | $2.03M | 32,661 | SEC↗ |
| Wang Xiaodong | Director | M Exercise | 2025-02-04 | 2025-02-06 | 41,760 | $6.50 | $271.4K | 41,760 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-02-04 | 2025-02-06 | 1,519 | $224.18 | $340.5K | 31,142 | SEC↗ |
| Wang Xiaodong | Director | M Exercise deriv | 2025-01-07 | 2025-01-08 | 542,880 | — | $0 | 2,714,407 | SEC↗ |
| Wang Xiaodong | Director | M Exercise | 2025-01-07 | 2025-01-08 | 41,760 | $6.50 | $271.4K | 41,760 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-01-07 | 2025-01-08 | 4,260 | $177.42 | $755.8K | 6,939 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-01-07 | 2025-01-08 | 19,251 | $175.46 | $3.38M | 22,509 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-01-07 | 2025-01-08 | 11,310 | $176.67 | $2.00M | 11,199 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-01-07 | 2025-01-08 | 1,301 | $179.18 | $233.1K | 0 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2025-01-07 | 2025-01-08 | 5,638 | $178.39 | $1.01M | 1,301 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise deriv | 2024-12-14 | 2024-12-17 | 1,300,000 | — | $0 | 10,100,500 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | M Exercise | 2024-12-14 | 2024-12-17 | 1,300,000 | $0.50 | $650.0K | 2,978,833 | SEC↗ |
| Wang Xiaodong | Director | M Exercise deriv | 2024-12-10 | 2024-12-12 | 542,880 | — | $0 | 3,257,287 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 993 | $191.78 | $190.4K | 2,399 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 7,063 | $184.83 | $1.31M | 32,097 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 9,956 | $185.73 | $1.85M | 22,141 | SEC↗ |
| Wang Xiaodong | Director | M Exercise | 2024-12-10 | 2024-12-12 | 41,760 | $6.50 | $271.4K | 41,760 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 300 | $195.67 | $58.7K | 0 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 725 | $194.01 | $140.7K | 300 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 1,374 | $192.61 | $264.6K | 1,025 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 2,600 | $183.60 | $477.4K | 39,160 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 1,833 | $190.57 | $349.3K | 3,392 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 1,300 | $188.79 | $245.4K | 5,225 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 6,350 | $187.60 | $1.19M | 6,525 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-12-10 | 2024-12-12 | 9,266 | $186.99 | $1.73M | 12,875 | SEC↗ |
| Baker Brothers Life Sciences L | Director | S Sale | 2024-12-09 | 2024-12-10 | 33,943 | $208.01 | $7.06M | 9,657,351 | SEC↗ |
| Baker Brothers Life Sciences L | Director | S Sale | 2024-12-09 | 2024-12-10 | 3,074 | $208.01 | $639.4K | 874,529 | SEC↗ |
| Baker Brothers Life Sciences L | Director | S Sale | 2024-12-09 | 2024-12-10 | 916,964 | $186.50 | $171.01M | 8,740,387 | SEC↗ |
| Baker Brothers Life Sciences L | Director | S Sale | 2024-12-09 | 2024-12-10 | 83,036 | $186.50 | $15.49M | 791,493 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-12-06 | 2024-12-10 | 0 | — | $0 | 0 | SEC↗ |
| HILLHOUSE INVESTMENT MANAGEMEN | 10% Owner | S Sale | 2024-12-02 | 2024-12-04 | 17,842,500 | $200.00 | $3.57B | 125,045,741 | SEC↗ |
| Wang Xiaodong | Director | M Exercise deriv | 2024-11-26 | 2024-11-29 | 499,993 | — | $0 | 7 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 12,293 | $191.22 | $2.35M | 7,388 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 700 | $191.05 | $133.7K | 19,681 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 6,187 | $190.32 | $1.18M | 20,381 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 200 | $189.76 | $38.0K | 26,568 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 1,475 | $190.31 | $280.7K | 3,608 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 2,725 | $191.24 | $521.1K | 883 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 883 | $191.89 | $169.4K | 0 | SEC↗ |
| Wang Xiaodong | Director | M Exercise | 2024-11-26 | 2024-11-29 | 38,461 | $6.50 | $250.0K | 40,468 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 4,425 | $187.16 | $828.2K | 36,043 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 300 | $187.61 | $56.3K | 35,743 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 5,875 | $187.98 | $1.10M | 29,868 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 400 | $188.55 | $75.4K | 29,468 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 2,700 | $189.17 | $510.8K | 26,768 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 1,014 | $187.15 | $189.8K | 6,869 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 6,981 | $191.96 | $1.34M | 0 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 407 | $191.81 | $78.1K | 6,981 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 1,186 | $188.08 | $223.1K | 5,683 | SEC↗ |
| Wang Xiaodong | Director | S Sale | 2024-11-26 | 2024-11-29 | 600 | $189.03 | $113.4K | 5,083 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 1,452 | $236.37 | $343.2K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 2,059 | $235.41 | $484.7K | 1,452 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 694 | $234.27 | $162.6K | 3,511 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 1,565 | $229.25 | $358.8K | 4,610 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 1,747 | $230.05 | $401.9K | 2,863 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 229 | $231.05 | $52.9K | 2,634 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 38 | $233.00 | $8.9K | 2,596 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 428 | $234.27 | $100.3K | 2,168 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 1,272 | $235.41 | $299.4K | 896 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 896 | $236.37 | $211.8K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 2,535 | $229.25 | $581.1K | 7,465 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 2,827 | $230.05 | $650.4K | 4,638 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 371 | $231.04 | $85.7K | 4,267 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-10-08 | 2024-10-10 | 62 | $233.00 | $14.4K | 4,205 | SEC↗ |
| Sharp Shalini | Director | A Award deriv | 2024-09-30 | 2024-10-02 | 17,238 | — | $0 | 17,238 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2024-09-30 | 2024-10-02 | 1,202 | $237.10 | $285.0K | 0 | SEC↗ |
| Sharp Shalini | Director | A Award | 2024-09-30 | 2024-10-02 | 8,151 | — | $0 | 8,151 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2024-09-27 | 2024-10-01 | 5,000 | $220.35 | $1.10M | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-09-19 | 2024-09-19 | 4,500 | $200.14 | $900.6K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-09-17 | 2024-09-19 | 500 | $200.00 | $100.0K | 4,500 | SEC↗ |
| Ball Titus B. | Principal Accounting Officer | S Sale | 2024-09-03 | 2024-09-05 | 137 | $189.94 | $26.0K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-09-03 | 2024-09-05 | 700 | $191.20 | $133.8K | 274 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-09-03 | 2024-09-05 | 2,275 | $190.29 | $432.9K | 974 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-09-03 | 2024-09-05 | 275 | $188.97 | $52.0K | 3,249 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-09-03 | 2024-09-05 | 274 | $192.04 | $52.6K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-09-03 | 2024-09-05 | 2,032 | $188.16 | $382.3K | 3,524 | SEC↗ |
| Wang Xiaodong | Director | G Gift | 2024-08-12 | 2024-08-14 | 301,457 | — | $0 | 5,266,973 | SEC↗ |
| Rosenberg Aaron | Chief Financial Officer | A Award deriv | 2024-08-09 | 2024-08-13 | 220,987 | — | $0 | 220,987 | SEC↗ |
| Rosenberg Aaron | Chief Financial Officer | A Award | 2024-08-09 | 2024-08-13 | 118,547 | — | $0 | 118,547 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2024-07-30 | 2024-08-01 | 834 | $160.57 | $133.9K | 0 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer | S Sale | 2024-07-01 | 2024-07-03 | 472 | $143.90 | $67.9K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-06-24 | 2024-06-26 | 400 | $160.12 | $64.0K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-06-24 | 2024-06-26 | 2,389 | $159.49 | $381.0K | 400 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-06-24 | 2024-06-26 | 23 | $161.27 | $3.7K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-06-24 | 2024-06-26 | 1,036 | $159.53 | $165.3K | 423 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-06-24 | 2024-06-26 | 400 | $160.38 | $64.2K | 23 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2024-06-24 | 2024-06-26 | 2 | $161.10 | $322 | 0 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2024-06-24 | 2024-06-26 | 1,062 | $159.80 | $169.7K | 2 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer | S Sale | 2024-06-24 | 2024-06-26 | 899 | $155.66 | $139.9K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-06-18 | 2024-06-20 | 300 | $155.15 | $46.5K | 300 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-06-18 | 2024-06-20 | 300 | $156.80 | $47.0K | 0 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-06-18 | 2024-06-20 | 1,121 | $153.66 | $172.3K | 1,506 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-06-18 | 2024-06-20 | 906 | $154.17 | $139.7K | 600 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2024-06-18 | 2024-06-20 | 841 | $153.75 | $129.3K | 0 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2024-06-17 | 2024-06-20 | 208 | $159.68 | $33.2K | 129 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2024-06-17 | 2024-06-20 | 129 | $159.74 | $20.6K | 0 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | S Sale | 2024-06-17 | 2024-06-20 | 102 | $158.20 | $16.1K | 337 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | S Sale | 2024-06-17 | 2024-06-20 | 627 | $159.00 | $99.7K | 2,627 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2024-06-17 | 2024-06-20 | 478 | $159.00 | $76.0K | 1,626 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2024-06-17 | 2024-06-20 | 485 | $159.42 | $77.3K | 1,141 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2024-06-17 | 2024-06-20 | 300 | $159.90 | $48.0K | 841 | SEC↗ |
| Wang Lai | Global Head of R&D | S Sale | 2024-06-17 | 2024-06-20 | 237 | $158.50 | $37.6K | 2,104 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer | S Sale | 2024-06-17 | 2024-06-20 | 154 | $158.24 | $24.4K | 762 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer | S Sale | 2024-06-17 | 2024-06-20 | 195 | $158.58 | $30.9K | 567 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer | S Sale | 2024-06-17 | 2024-06-20 | 253 | $159.00 | $40.2K | 314 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer | S Sale | 2024-06-17 | 2024-06-20 | 314 | $159.74 | $50.2K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-06-17 | 2024-06-20 | 608 | $159.40 | $96.9K | 376 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-06-17 | 2024-06-20 | 297 | $158.53 | $47.1K | 984 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-06-17 | 2024-06-20 | 376 | $159.91 | $60.1K | 0 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award deriv | 2024-06-05 | 2024-06-07 | 68,302 | — | $0 | 68,302 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award deriv | 2024-06-05 | 2024-06-07 | 68,302 | — | $0 | 68,302 | SEC↗ |
| Yi Qingqing | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 34,151 | — | $0 | 34,151 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer | A Award deriv | 2024-06-05 | 2024-06-07 | 256,659 | — | $0 | 256,659 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 34,151 | — | $0 | 34,151 | SEC↗ |
| Wang Xiaodong | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 410,657 | — | $0 | 410,657 | SEC↗ |
| Riva Alessandro | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 34,151 | — | $0 | 34,151 | SEC↗ |
| Glazer Donald W. | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 34,151 | — | $0 | 34,151 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | A Award deriv | 2024-06-05 | 2024-06-07 | 923,975 | — | $0 | 923,975 | SEC↗ |
| HOOPER ANTHONY C | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 34,151 | — | $0 | 34,151 | SEC↗ |
| BRANDICOURT OLIVIER | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 34,151 | — | $0 | 34,151 | SEC↗ |
| Dugan Margaret | Director | A Award deriv | 2024-06-05 | 2024-06-07 | 34,151 | — | $0 | 34,151 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | A Award deriv | 2024-06-05 | 2024-06-07 | 184,795 | — | $0 | 184,795 | SEC↗ |
| Wang Lai | Global Head of R&D | A Award deriv | 2024-06-05 | 2024-06-07 | 318,253 | — | $0 | 318,253 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | A Award deriv | 2024-06-05 | 2024-06-07 | 477,386 | — | $0 | 477,386 | SEC↗ |
| Ball Titus B. | Principal Accounting Officer | A Award deriv | 2024-06-05 | 2024-06-07 | 15,340 | — | $0 | 15,340 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2024-06-05 | 2024-06-07 | 32,682 | — | $0 | 126,099 | SEC↗ |
| BAKER BROS. ADVISORS LP | Director, 10% Owner | A Award | 2024-06-05 | 2024-06-07 | 32,682 | — | $0 | 126,095 | SEC↗ |
| Yi Qingqing | Director | A Award | 2024-06-05 | 2024-06-07 | 16,341 | — | $0 | 45,955 | SEC↗ |
| Wang Julia Aijun | Chief Financial Officer | A Award | 2024-06-05 | 2024-06-07 | 136,240 | — | $0 | 456,326 | SEC↗ |
| Sanders Corazon (Corsee) D. | Director | A Award | 2024-06-05 | 2024-06-07 | 16,341 | — | $0 | 46,241 | SEC↗ |
| Wang Xiaodong | Director | A Award | 2024-06-05 | 2024-06-07 | 108,992 | — | $0 | 5,568,430 | SEC↗ |
| Riva Alessandro | Director | A Award | 2024-06-05 | 2024-06-07 | 16,341 | — | $0 | 45,955 | SEC↗ |
| Glazer Donald W. | Director | A Award | 2024-06-05 | 2024-06-07 | 16,341 | — | $0 | 2,718,464 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | A Award | 2024-06-05 | 2024-06-07 | 490,464 | — | $0 | 1,812,018 | SEC↗ |
| HOOPER ANTHONY C | Director | A Award | 2024-06-05 | 2024-06-07 | 16,341 | — | $0 | 53,755 | SEC↗ |
| BRANDICOURT OLIVIER | Director | A Award | 2024-06-05 | 2024-06-07 | 16,341 | — | $0 | 16,341 | SEC↗ |
| Dugan Margaret | Director | A Award | 2024-06-05 | 2024-06-07 | 16,341 | — | $0 | 45,955 | SEC↗ |
| Lee Chan Henry | SVP, General Counsel | A Award | 2024-06-05 | 2024-06-07 | 98,085 | — | $0 | 269,399 | SEC↗ |
| Wang Lai | Global Head of R&D | A Award | 2024-06-05 | 2024-06-07 | 168,935 | — | $0 | 1,768,962 | SEC↗ |
| Wu Xiaobin | President, COO & GM China | A Award | 2024-06-05 | 2024-06-07 | 253,409 | — | $0 | 1,268,849 | SEC↗ |
| Ball Titus B. | Principal Accounting Officer | A Award | 2024-06-05 | 2024-06-07 | 24,427 | — | $0 | 47,905 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-04-11 | 2024-04-11 | 4,265 | $146.82 | $626.2K | 2,811 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-04-11 | 2024-04-11 | 5,008 | $146.09 | $731.6K | 7,076 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-04-11 | 2024-04-11 | 2,811 | $147.74 | $415.3K | 0 | SEC↗ |
| OYLER JOHN | Chief Executive Officer | S Sale | 2024-04-10 | 2024-04-11 | 60 | $150.85 | $9.1K | 12,084 | SEC↗ |